Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Toward Electronic Health Recording: Evaluation of Electronic Patient-reported Outcome Measures System for Remote
Yasser El Miedany1,2, Maha El Gaafary3,4, Sally Youssef3,4
1From King's College, London, UK; Rheumatology and Rehabilitation, and Community and Public Health, Ain Shams University, Cairo, Egypt; Rheumatology Department, King Abdel Aziz University, Jeddah, Saudi Arabia; Rheumatology and Rehabilitation, Tanta University, Tanta; Internal Medicine, Cairo University, Egypt; Rheumatology, North Middlesex University Hospitals, London, UK. drelmiedany@rheumatology4u.com.
Objective:
To assess the use of electronic patient-reported outcome measures (ePROM) in standard clinical practice for early rheumatoid arthritis (RA) management, the ePROM ability to enhance clinical care, and how computing technology can improve the patients' adherence to therapy.
Methods:
In a double-blinded randomized-controlled study, 211 patients with early RA diagnosed according to American College of Rheumatology/European League Against Rheumatism criteria completed a PROM in paper format at their first clinic visit. Patients were then randomized to Group 1, which completed an ePROM questionnaire monthly, or Group 2, which continued the standard paper PROM format. Over a 12-month period, Group 1 patients were assessed every 3 months in the clinic, whereas Group 2 patients were assessed in the clinic initially monthly for 6 months, then every 3 months. The primary endpoint was the equivalence of outcomes [Routine Assessment of Patient Index Data 3 (RAPID-3) and 28-joint Disease Activity Score (DAS28)] in both groups. The secondary endpoint was the patients' adherence to their medications.
Results:
There was no significant difference between disease activity measures as well as DAS28 and RAPID-3 scores at 3, 6, and 12 months of management, although there was a trend toward lower patient-reported tender joint count and functional disability score in the active group versus the control group. The patients' adherence to antirheumatic therapy was significantly higher (p < 0.01) in the ePROM group, whereas stopping disease-modifying antirheumatic drugs for intolerability was significantly higher (p < 0.01) in the control group at 12 months of treatment.
Conclusion:
We found ePROM equivalent to standard paper PROM format. Further, it enabled the patients to personally monitor how they are doing regarding their disease activity and helped to optimize their adherence to their treatment.
Related Concept Videos
Methods of Documentation VII: EMR
Rheumatic Heart Disease IV: Nursing Management
Holter Monitor: 24-Hour Monitoring
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

